SHIVA GUPTA to Carcinoma, Renal Cell
This is a "connection" page, showing publications SHIVA GUPTA has written about Carcinoma, Renal Cell.
Connection Strength
0.919
-
Tuberous Sclerosis Complex (TSC): Renal and Extrarenal Imaging. Acad Radiol. 2022 03; 29(3):439-449.
Score: 0.308
-
Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC). Abdom Radiol (NY). 2020 06; 45(6):1872-1882.
Score: 0.295
-
Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 2015 May; 204(5):1031-41.
Score: 0.207
-
Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy. AJR Am J Roentgenol. 2017 Dec; 209(6):1278-1284.
Score: 0.062
-
Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT. Abdom Imaging. 2014 Feb; 39(1):66-85.
Score: 0.048